Authors
Michael X Repka , Raymond T Kraker , Jonathan M Holmes , Allison I Summers , Stephen R Glaser , Carmen N Barnhardt , David R Tien

Atropine vs patching for treatment of moderate amblyopia: follow-up at 15 years of age of a randomized clinical trial

publication date
Category
see more

Abstract/Introduction

Importance: Initial treatment for amblyopia of the fellow eye with patching and atropine sulfate eyedrops improves visual acuity. Long-term data on the durability of treatment benefit are needed.

 

Objective: To report visual acuity at 15 years of age among patients who were younger than 7 years when enrolled in a treatment trial for moderate amblyopia.

 

Design, setting, and participants: In a multicenter clinical trial, 419 children with amblyopia (visual acuity, 20/40 to 20/100) were randomly assigned to patching (minimum of 6 h/d) or atropine sulfate eyedrops, 1% (1 drop daily), for 6 months. Treatment after 6 months was at the discretion of the investigator. Two years after enrollment, an unselected subgroup of 188 children were enrolled into long-term follow-up.

 

Intervention: Initial treatment with patching or atropine with subsequent treatment at investigator discretion.

Main outcomes and measures: Visual acuity at 15 years of age with the electronic Early Treatment Diabetic Retinopathy Study test in amblyopic and fellow eyes.


Conclusion/Results

Results: Mean visual acuity in the amblyopic eye measured in 147 participants at 15 years of age was 0.14 logMAR (approximately 20/25); 59.9% of amblyopic eyes had visual acuity of 20/25 or better and 33.3%, 20/20 or better. Mean interocular acuity difference (IOD) at 15 years of age was 0.21 logMAR (2.1 lines); 48.3% had an IOD of 2 or more lines and 71.4%, 1 or more lines. Treatment (other than spectacles) was prescribed for 9 participants (6.1%) aged 10 to 15 years. Mean IOD was similar at examinations at 10 and 15 years of age (2.0 and 2.1 logMAR lines, respectively; P = .39). Better visual acuity at the 15-year examination was achieved in those who were younger than 5 years at the time of entry into the randomized clinical trial (mean logMAR, 0.09) compared with those aged 5 to 6 years (mean logMAR, 0.18; P < .001). When we compared subgroups based on original treatment with atropine or patching, no significant differences were observed in visual acuity of amblyopic and fellow eyes at 15 years of age (P = .44 and P = .43, respectively).

Conclusions and relevance: At 15 years of age, most children treated for moderate amblyopia when younger than 7 years have good visual acuity, although mild residual amblyopia is common. The outcome is similar regardless of initial treatment with atropine or patching. The results indicate that improvement occurring with amblyopia treatment is maintained until at least 15 years of age.


Testimonials


  • Vision therapy is well worth the response, time and effort. Our Son had a hard time focusing and writing neatly. After vision therapy Seth could complete a task in half the time if previously took. His abilities to focus improved greatly and so did his handwriting.

    Also, he was better at listening. As a parent, we wanted learning to be fun for our Son, and vision therapy made this possible.


    Amanda T.

  • Vision Therapy is well worth the expense, time and effort. Our son had a hard time focusing handwriting neatly. After vision therapy Seth could complete a task in half the time it previously took his abilities to focus and improved greatly and so did his handwriting.

    Also, he was better at listening. As a parent you wanted learning to be fun for our son and vision therapy made this possible.


    Alexa H.

  • Vision Therapy has given or son the tools he needs to be able to scan and read the written word more effectively and efficiently.

    He love working with John and these working sessions give him the motivation to gladly work on his homework assignments.

    It amazed us to see the difference in the tracking of his eyes and along a line of it's from the beginning to the end of the treatment.

    Dr. McBryar , Kristen and John  are all marvelous and we would recommend them to anyone I only wish that we would have found them sooner!


    Charlotte M.

  • Prior to coming to the institute for vision development my son complained of daily headaches. Therapy has eliminated his headaches completely. I love knowing my son is able to learn pain-free for the rest of his life because of the work that has been done over just a few weeks in this office. He he absolutely loved coming that didn't even feel like going to a doctor or therapy. We are grateful for the relief he was able to find by coming here.

    Thank you!


    Olivia C.

  • Seems much less frustrated with life

    Reads non-stop and fast

    Spelling abilities have been hugely improved

    Seems much more confident

    Thank You!!!


    Kelly O.

Blog

group-of-small-nursery-school-children-with-teache-W2UF5RU

Vision Among Us

One of the challenges with visual impairments and visual deficits is that it's difficult to detect them just by looking […]

Read More
frustrated-millennial-businessman-having-strong-headache-tired-from-laptop-work

Vision Therapy for Neurological Conditions

Each year an estimated 1.5 million Americans sustain a traumatic brain injury (TBI). According to the Neuro Optometric Rehabilitation Association, […]

Read More
DSC_2077

Vision Therapy for Adults

Adults generally accept changes in themselves as part of aging, and think that there's nothing they can do about it. […]

Read More
see all blogs

Contact Us To Amplify Your EyeCare

Working Hours

Monday - Thursday
8:00 am - 5:15pm
friday-sunday
Closed
Location
1043 Executive Drive Suite #101 Hixson, TN 37343
Website Accessibility Policy
Safety protocols page
phone-handsetarrow-uparrow-right linkedin facebook pinterest youtube rss twitter instagram facebook-blank rss-blank linkedin-blank pinterest youtube twitter instagram